The CD20/alphaCD20 'suicide' system: novel vectors with improved safety and expression profiles and efficient elimination of CD20-transgenic T cells.

T. van Meerten; M.J. Claessen; A. Hagenbeek; S.B. Ebeling

The CD20/alphaCD20 'suicide' system: novel vectors with improved safety and expression profiles and efficient elimination of CD20-transgenic T cells.

Translated title of the contribution: The CD20/alphaCD20 'suicide' system: novel vectors with improved safety and expression profiles and efficient elimination of CD20-transgenic T cells.

T. van Meerten
, M.J. Claessen
, A. Hagenbeek
, S.B. Ebeling

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	The CD20/alphaCD20 'suicide' system: novel vectors with improved safety and expression profiles and efficient elimination of CD20-transgenic T cells.
Original language	Undefined/Unknown
Pages (from-to)	789-797
Number of pages	9
Journal	Gene Therapy
Volume	13
Issue number	9
Publication status	Published - 2006

Cite this

@article{b8d3cb0419994914834f9f1311e7fbca,

title = "The CD20/alphaCD20 'suicide' system: novel vectors with improved safety and expression profiles and efficient elimination of CD20-transgenic T cells.",

author = "\{van Meerten\}, T. and M.J. Claessen and A. Hagenbeek and S.B. Ebeling",

year = "2006",

language = "Undefined/Unknown",

volume = "13",

pages = "789--797",

journal = "Gene Therapy",

issn = "0969-7128",

publisher = "Springer Nature",

number = "9",

}